NCT04721301 2023-10-17
Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial
University Hospital Heidelberg
Phase 1 Completed
Clinical Trials
6 trialsNCT03274804 2022-06-07
PICCASSO
University Hospital Heidelberg
Phase 1 Completed
NCT01276236 2021-03-05
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
University of California, San Francisco
Phase 2 Completed
NCT01785810 2021-01-11
Phase II Maraviroc for GVHD Prevention
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT01736813 2017-03-22
MARACON
National Center for Tumor Diseases, Heidelberg
Completed
NCT02799888 2016-06-15
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
Affiliated Hospital to Academy of Military Medical Sciences
Phase 2 Unknown